|
1) Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999; 832: 146-54
|
|
|
|
|
2) Oike Y, Yasunaga K, Ito Y, et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration. Proc Natl Acad Sci U S A. 2003; 100: 9494-9
|
|
|
|
|
3) Oike Y, Ito Y, Maekawa H, et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood. 2004; 103: 3760-5
|
|
|
|
|
|
4) Oike Y, Akao M, Yasunaga K, et al. Angiopoietin-related growth factor (AGF) antagonizes obesity and related insulin resistance. Nat Med. 2005; 11: 400-8
|
|
|
|
|
|
5) Morisada T, Kubota Y, Urano T, et al. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium. 2006; 13: 71-9
|
|
|
|
|
|
6) Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999; 13: 1055-66
|
|
|
|
|
|
7) Oike Y, Yasunaga K, Suda T. Angiopoietin-related/like protein (ARPs/Angptls) regulate angiogenesis. Int J Hematol. 2004; 80: 21-8
|
|
|
|
|
8) Oike Y, Akao M, Kubota Y, et al. Angiopoietin-like proteins: potential new targets for therapy of metabolic syndrome. Trends Mol Med. 2005; 11: 473-9
|
|
|
|
|
|
9) Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 2008; 18: 6-14
|
|
|
|
|
|
10) Urano T, Ito Y, Akao M, et al. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler Thromb Vasc Biol. 2008; 28: 827-34
|
|
|
|
|
|
11) Zhang Y, Hu X, Tian R, et al. Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins. Biochem Biophys Res Commun. 2006; 347: 100-8
|
|
|
|
|